278 related articles for article (PubMed ID: 15860254)
1. RALES, EPHESUS and redox.
Funder JW
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):121-5. PubMed ID: 15860254
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone as a cardiovascular risk factor.
Rossi G; Boscaro M; Ronconi V; Funder JW
Trends Endocrinol Metab; 2005 Apr; 16(3):104-7. PubMed ID: 15808807
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
4. Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockade.
Funder JW
Future Cardiol; 2006 Sep; 2(5):535-41. PubMed ID: 19804189
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone, mineralocorticoid receptors and vascular inflammation.
Funder JW
Mol Cell Endocrinol; 2004 Mar; 217(1-2):263-9. PubMed ID: 15134827
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptors: distribution and activation.
Funder JW
Heart Fail Rev; 2005 Jan; 10(1):15-22. PubMed ID: 15947887
[TBL] [Abstract][Full Text] [Related]
8. Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system.
Mihailidou AS; Funder JW
Steroids; 2005; 70(5-7):347-51. PubMed ID: 15862816
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone target organ protection by eplerenone.
Rudolph AE; Rocha R; McMahon EG
Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor and cardiac arrhythmia.
Gravez B; Tarjus A; Jaisser F
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):910-5. PubMed ID: 23888997
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone, mineralocorticoid receptor, and heart failure.
Messaoudi S; Azibani F; Delcayre C; Jaisser F
Mol Cell Endocrinol; 2012 Mar; 350(2):266-72. PubMed ID: 21784127
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone and mineralocorticoid receptors in the cardiovascular system.
Funder JW
Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957
[TBL] [Abstract][Full Text] [Related]
14. Induction of cardiac fibrosis by aldosterone.
Lijnen P; Petrov V
J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone, hypertension and heart failure: insights from clinical trials.
Funder JW
Hypertens Res; 2010 Sep; 33(9):872-5. PubMed ID: 20631715
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptors: emerging complexity and functional diversity.
Odermatt A; Atanasov AG
Steroids; 2009 Feb; 74(2):163-71. PubMed ID: 19022273
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
Shah NC; Pringle S; Struthers A
J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):20-30. PubMed ID: 17083070
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies.
Pasquale PD; Stefano GD; Paterna S
Ital Heart J; 2000 Sep; 1(9):595-604. PubMed ID: 11130838
[TBL] [Abstract][Full Text] [Related]
19. Interactions of high salt intake and the response of the cardiovascular system to aldosterone.
Conlin PR
Cardiol Rev; 2005; 13(3):118-24. PubMed ID: 15831143
[TBL] [Abstract][Full Text] [Related]
20. Why are mineralocorticoid receptor antagonists cardioprotective?
Chai W; Danser AH
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):153-62. PubMed ID: 17075718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]